Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen E Heslop

Showing results (1-10 of 271) with videos related to

Pageof 28
Sort By:
Blood|September 3, 2009
How I treat EBV lymphoproliferationHelen E Heslop
Blood|January 6, 2023
Introduction to a review series on banked allogeneic immune effector cellsHelen E Heslop
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 4, 2014
Combining drugs and biologics to treat nasopharyngeal cancerHelen E Heslop
Transplantation and Cellular Therapy|March 14, 2024
Long-Term Follow-Up for Recipients of Genetically Modified Cells: A Team EffortHelen E Heslop
Blood|April 23, 2011
A less sour sweet; blocking galectinHelen E Heslop
Blood|October 1, 2011
TCR expression; quantitative easing by CD3Helen E Heslop
Blood|March 17, 2012
Equal-opportunity treatment of EBV-PTLDHelen E Heslop
Blood|May 22, 2020
Sensitizing Burkitt lymphoma to EBV-CTLsHelen E Heslop
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 27, 2006
Commentary on journal of immunotherapy paper by melenhorst et alHelen E Heslop
Blood|March 17, 2023
Introduction to a How I Treat series on emergent CAR T-cell toxicitiesHelen E Heslop
Pageof 28

Showing results (1-10 of 271) with videos related to

Sort By:
Pageof 28
Blood|September 3, 2009
How I treat EBV lymphoproliferationHelen E Heslop
Blood|January 6, 2023
Introduction to a review series on banked allogeneic immune effector cellsHelen E Heslop
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 4, 2014
Combining drugs and biologics to treat nasopharyngeal cancerHelen E Heslop
Transplantation and Cellular Therapy|March 14, 2024
Long-Term Follow-Up for Recipients of Genetically Modified Cells: A Team EffortHelen E Heslop
Blood|April 23, 2011
A less sour sweet; blocking galectinHelen E Heslop
Blood|October 1, 2011
TCR expression; quantitative easing by CD3Helen E Heslop
Blood|March 17, 2012
Equal-opportunity treatment of EBV-PTLDHelen E Heslop
Blood|May 22, 2020
Sensitizing Burkitt lymphoma to EBV-CTLsHelen E Heslop
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 27, 2006
Commentary on journal of immunotherapy paper by melenhorst et alHelen E Heslop
Blood|March 17, 2023
Introduction to a How I Treat series on emergent CAR T-cell toxicitiesHelen E Heslop
Pageof 28